A carregar...

Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis

Objective: To review the safety and efficacy of romosozumab (Evenity) in the treatment of osteoporosis in women. Data Sources: An English-language search of PubMed and Medline (1966 to August 2020) was conducted using the keywords romosozumab, sclerostin inhibitor, AMG785, and osteoporosis. Manufact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharm Technol
Main Authors: Miller, Shannon A., St. Onge, Erin Lyn, Whalen, Karen L.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7809324/
https://ncbi.nlm.nih.gov/pubmed/34752536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122520967632
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!